Nicaragua vs Singapore: Previously treated cases tested for RR-/MDR-TB
Nicaragua
51.0%
in 2023
Singapore
49.0%
in 2024
Nicaragua rank
149th
Singapore rank
151st
Previously treated cases tested for RR-/MDR-TB over time
- Nicaragua
- Singapore
How they compare
Nicaragua currently reports 51.0% against 49.0% in Singapore, a difference of 2.0%.
The two have swapped places 6 times across 18 shared years of data; in 2005 it was Singapore ahead.
Nicaragua ranks 149th and Singapore ranks 151st of 180 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Nicaragua | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.2% | 67.2% | 16.0% | Singapore |
| 2010s | 57.2% | 68.5% | 11.3% | Singapore |
| 2020s | 61.8% | 78.0% | 16.2% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Nicaragua or Singapore?
- Nicaragua, at 51.0% against 49.0% in Singapore as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Nicaragua and Singapore?
- 2.0%, with Nicaragua ahead.
- How many years of comparable data are there for Nicaragua and Singapore?
- 18 years are reported by both, from 2005 to 2023.
- How do Nicaragua and Singapore rank globally for previously treated cases tested for rr-/mdr-tb?
- Nicaragua ranks 149th and Singapore ranks 151st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.